Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol. 2012 Dec 20; 30(36):4584-6; author reply 4588-9.